BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 20059638)

  • 1. Anandamide induces cell death through lipid rafts in hepatic stellate cells.
    Yang Q; Liu HY; Zhang YW; Wu WJ; Tang WX
    J Gastroenterol Hepatol; 2010 May; 25(5):991-1001. PubMed ID: 20059638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts].
    Liao YS; Wu J; Wang P; Zhang H
    Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):256-9. PubMed ID: 21575494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anandamide induces necrosis in primary hepatic stellate cells.
    Siegmund SV; Uchinami H; Osawa Y; Brenner DA; Schwabe RF
    Hepatology; 2005 May; 41(5):1085-95. PubMed ID: 15841466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells].
    Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX
    Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of anandamide on the activation and proliferation of hepatic stellate cells through cannabinoid-2 receptors].
    Liu HY; Yang Q; Duan RX; Zhang YW; Tang WX
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):430-4. PubMed ID: 18578993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Kokona D; Thermos K
    Exp Eye Res; 2015 Jul; 136():45-58. PubMed ID: 25989217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes.
    Wojtalla A; Herweck F; Granzow M; Klein S; Trebicka J; Huss S; Lerner R; Lutz B; Schildberg FA; Knolle PA; Sauerbruch T; Singer MV; Zimmer A; Siegmund SV
    Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G873-87. PubMed ID: 22301114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of hepatic tumour necrosis factor-alpha attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers.
    Yang YY; Lee KC; Huang YT; Lee FY; Chau GY; Loong CC; Lin HC; Lee SD
    Liver Int; 2009 May; 29(5):678-85. PubMed ID: 19413671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: involvement of both mitochondrial and death receptor pathways.
    Costa MA; Fonseca BM; Teixeira NA; Correia-da-Silva G
    Placenta; 2015 Jan; 36(1):69-76. PubMed ID: 25465706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anandamide enhances expression of heat shock protein 72 to protect against ischemia-reperfusion injury in rat heart.
    Li Q; Shi M; Li B
    J Physiol Sci; 2013 Jan; 63(1):47-53. PubMed ID: 23007622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.
    Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T
    Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells.
    Bari M; Spagnuolo P; Fezza F; Oddi S; Pasquariello N; Finazzi-Agrò A; Maccarrone M
    J Immunol; 2006 Oct; 177(8):4971-80. PubMed ID: 17015679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells. Implications for anandamide-induced apoptosis.
    Bari M; Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
    J Biol Chem; 2005 Apr; 280(13):12212-20. PubMed ID: 15657045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts.
    Sarker KP; Maruyama I
    Cell Mol Life Sci; 2003 Jun; 60(6):1200-8. PubMed ID: 12861385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.
    Brighton PJ; McDonald J; Taylor AH; Challiss RA; Lambert DG; Konje JC; Willets JM
    Mol Endocrinol; 2009 Sep; 23(9):1415-27. PubMed ID: 19477951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction.
    Sánchez MG; Ruiz-Llorente L; Sánchez AM; Díaz-Laviada I
    Cell Signal; 2003 Sep; 15(9):851-9. PubMed ID: 12834810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.
    Cencioni MT; Chiurchiù V; Catanzaro G; Borsellino G; Bernardi G; Battistini L; Maccarrone M
    PLoS One; 2010 Jan; 5(1):e8688. PubMed ID: 20098669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endocannabinoid anandamide induces apoptosis of rat decidual cells through a mechanism involving ceramide synthesis and p38 MAPK activation.
    Fonseca BM; Correia-da-Silva G; Teixeira NA
    Apoptosis; 2013 Dec; 18(12):1526-35. PubMed ID: 24048885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anandamide-induced cell death: dual effects in primary rat decidual cell cultures.
    Fonseca BM; Correia-da-Silva G; Teixeira NA
    Placenta; 2009 Aug; 30(8):686-92. PubMed ID: 19560819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation.
    Habayeb OM; Taylor AH; Bell SC; Taylor DJ; Konje JC
    Endocrinology; 2008 Oct; 149(10):5052-60. PubMed ID: 18599552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.